Ateb, a provider of pharmacy patient care solutions, has announced the formation of its inaugural Community Pharmacy Advisory Board, comprised of pharmacy leaders who will serve as an “internal institute” within the Ateb organization.
Despite high-profile efforts to implement abuse-deterrent labels and properties on brand-name opioids, advisory company Avalere Health’s latest research notes a key blind spot in the efforts — accessibility.
The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM).
Fruth Pharmacy has unveiled new technology to make prescription label reading easier for the visually impaired by partnering with AccessaMed to bring a special prescription label into all 26 Fruth Pharmacy locations.
In a new survey of approximately 2,700 American customers, the Canadian International Pharmacy Association found continued demand for safely ordering prescription medications online from licensed Canadian pharmacies.
The Food and Drug Administration has approved Boehringer Ingelheim, Inc.'s Stiolto Respimat (tiotropium bromide and olodaterol), a once-daily inhaler meant to treat obstructed airflow in patients, the company announced Tuesday.
The complex issue of prescription drug abuse and access are not receiving the comprehensive approach that they deserve and greater collaboration is needed among all stakeholders to help find solutions. That was a key message that National Association of Chain Drug Stores CEO Steve Anderson and U.S. Pain Foundation president Paul Gileno shared in a joint op-ed published Tuesday in The Tampa Tribune.